The tumor suppressor gene TP53, encoding p53, is expressed as several transcripts. The fully spliced p53 (FSp53) transcript encodes the canonical p53 protein. The alternatively spliced p53I2 transcript retains intron 2 and encodes D40p53 (or DNp53), an isoform lacking first 39 N-terminal residues corresponding to the main transactivation domain. We demonstrate the formation of G-quadruplex structures (G4) in a GC-rich region of intron 3 that modulates the splicing of intron 2. First, we show the formation of G4 in synthetic RNAs encompassing intron 3 sequences by ultraviolet melting, thermal difference spectra and circular dichroism spectroscopy. These observations are confirmed by detection of G4-induced reverse transcriptase elongation stops in synthetic RNA of intron 3. In this region, p53 pre-messenger RNA (mRNA) contains a succession of short exons (exons 2 and 3) and introns (introns 2 and 4) covering a total of 333 bp. Site-directed mutagenesis of Gtracts putatively involved in G4 formation decreased by $30% the excision of intron 2 in a green fluorescent protein-reporter splicing assay. Moreover, treatment of lymphoblastoid cells with 360A, a synthetic ligand that binds to single-strand G4 structures, increases the formation of FSp53 mRNA and decreases p53I2 mRNA expression. These results indicate that G4 structures in intron 3 regulate the splicing of intron 2, leading to differential expression of transcripts encoding distinct p53 isoforms.
Introduction
The tumor suppressor p53 protein controls antiproliferative responses to various forms of stress (1) . Its function is impaired in .50% of human cancer, mainly by mutation (2) . TP53 gene expression is complex, with different transcripts encoding isoforms carrying distinct N-and C-termini (3, 4) . To date, 10 isoforms have been identified resulting from the usage of alternative promoters, splice sites and/or translational initiation sites (5) . Several of these isoforms differ in their N-terminal region. The N-terminus of p53 contains the main transactivation domain (residues 1-42, transactivation domain I) as well as the binding site of Hdm2, which targets p53 for proteasome degradation and regulates p53 stability (1) . Transcription of p53 messenger RNA (mRNA) from the proximal promoter generates two proteins with distinct N-terminal domain. The first corresponds to the canonical p53 protein, assembled from the fully spliced p53 (FSp53) mRNA that retains 11 exons. This protein induces p53-mediated growth suppression in response to stress. The second isoform, D40p53 (or DNp53), is assembled from an alternatively spliced mRNA retaining intron 2 (p53I2) and lacks the first 39 residues, corresponding to transactivation domain I, as well as Hdm2-binding site (3, 6) . The use of an internal promoter located in a region between intron 1 and exon 5 generates a third N-terminal isoform, D133p53, which lacks the first 132 residues (5) .
When expressed in excess to p53, D40p53 inhibits transcriptional activity and interferes in the control of cell cycle progression and apoptosis by exerting a negative effect on the expression of p53-target genes (3, 6, 7) . However, the biological circumstances and the molecular mechanisms regulating D40p53 expression are still poorly known. Retention of intron 2 in p53I2 mRNA introduces several stop codons in the reading frame of AUG 1, thus preventing the synthesis of a full-length p53 protein. However, p53I2 mRNA can be translated using AUG 40 as initiation site, generating a protein isoform which differs from the canonical p53 by the lack of the first 39 residues. Expression of p53I2 transcript has been reported in cell lines, such as MCF-7, in normal lymphocytes and in primary melanoma isolates (7, 8) . However, the mechanism that regulates the splicing of p53 pre-mRNA into FSp53 or p53I2 is not understood. D40p53 protein isoform can also be produced by internal ribosomal entry site-regulated internal initiation of translation using FSp53 mRNA (9, 10) .
In recent years, it has been proposed that tridimensional RNA structures such as G-quadruplexes may play important roles in regulating splicing (11) . These structures result of the propensity of G-rich sequences to fold into four-stranded cation-dependent structures (12) . They are formed by the interaction of four guanines organized in a cyclic Hoogsteen hydrogen bonding arrangement termed a G-quartet and by the stacking of several G-quartets ( Figure 1A ). It is estimated that over 376 000 sequences in the human genome have the potential to adopt G-quadruplex structures, most of them located in non-coding regions (13, 14) . At the RNA level, G-quadruplexes may play a number of roles. In non-coding RNAs, they can affect their structures and functions (15, 16) . In 5#-untranslated region of mRNAs, G-quadruplexes have been shown to modulate translation (17, 18) . When present in introns, G-quadruplexes can affect the splicing and expression patterns of genes such as hTERT (human telomerase reverse transcriptase), BclxL or FMRP (Fragile X mental retardation protein) (11, 19, 20) .
The sequence of intron 3 in TP53 contains tracts of G bases organized in a pattern similar to the one of regions forming G-quadruplex structures. Since exon 3 in TP53 is extremely short (22 bp), we reasoned that motifs located in intron 3 might have an effect on the regulation of the splicing of intron 2. In this study, we provide an evidence for the formation of G-quadruplex in TP53 intron 3 and that these G-quadruplex structures may affect the splicing of intron 2, modulating the synthesis of either FSp53 (intron 2 spliced out) or p53I2 (intron 2 retained) mRNAs, which encode different p53 protein isoforms.
Materials and methods
Synthetic RNA oligomers and compounds RNA oligomers derived from intron 3 of p53 RNA and containing several Gtracts ( Figure 1B and C, Table I ) were synthesized from IBA (Göttingen, Germany) at 0.2 lmol scale and resuspended in 20-40 ll of bidistilled water (ddH 2 O). Concentrations of oligomers were determined by ultraviolet (UV) absorbance. The compound 360A [ (2, 6 -N,N#-methyl-quinolinio-3-yl)-pyridine dicarboxamide] was stored in dimethyl sulfoxide and further diluted in ddH 2 O for treating lymphoblastoid cell line for 48 h (21).
Abbreviations: CD, circular dichroism; FSp53, fully spliced p53; GFP, green fluorescent protein; mRNA, messenger RNA; PCR, polymerase chain reaction; RT, reverse transcriptase; TDS, thermal difference spectra; UV, ultraviolet.
UV melting
The thermal stability of oligonucleotides was characterized in heating/cooling experiments by recording UV absorbance at 295 nm as a function of temperature using an Uvikon XL UV/Vis spectrophotometer (22) . UV-melting experiments were conducted as described previously in 10 mM lithium cacodylate buffer, pH 7.2 containing either 100 mM LiCl, 100 mM NaCl or KCl at concentrations of 2 or 10 mM (23). Oligomers were tested at 3 lM strand concentration. The heating and cooling rates were 0.2°C/min. Experiments were performed in 1 cm path length quartz cuvettes.
UV thermal difference spectra Thermal difference spectra (TDS) were obtained by difference between the absorbance spectra from unfolded (at high temperature, .90°C) and folded oligonucleotides (at low temperature, $3°C). TDS provide specific signatures demonstrating G-quadruplex formation (24) . Spectra were recorded between 220 and 330 nm at pH 7.0 in 100 mM NaCl in an Uvikon XL UV/Vis spectrophotometer using quartz cuvettes with an optical path length of 1 cm. RNA strand concentration was 3 M.
Circular dichroism spectroscopy Circular dichroism (CD) spectra were recorded between 200 and 330 nm on a JASCO-810 spectropolarimeter as described previously (25) . Spectra were recorded after heating/cooling experiment and at low temperature (.4°C). Oligomers were tested at 3 M strand concentration.
Fluorescence resonance energy transfer melting assay
The F21T oligonucleotide, mimicking human telomeric motifs and doublelabeled with FAM and TAMRA at either end, was synthesized by Eurogentec (Seraing, Belgium) (Table I) . Briefly, in the presence of 360A, this oligonucleotide folds into a stable G-quadruplex, thus allowing fluorescence transfer to occur. The melting of the F21T probe was recorded by measuring fluorescence emission as a function of temperature. Different unlabeled oligomers were used as competitors, including the G-quadruplex-forming Oligos 1, 2 and 3, the non-G-quadruplex forming Oligo4 and two negative control oligonucleotides which do not contain G-tracts (Table I) (26, 27) .
Reverse transcriptase elongation assay Intron 3 RNA was synthesized by in vitro transcription with T7 RNA polymerase (Promega, Madison, WI) of a linearized pBSK plasmids containing intron 3. One microgram of pBSK, denatured in 0.2 N NaOH and 0.2 mM ethylenediaminetetraacetic acid (37°C 30 min), was sequenced using Sequenase T7 (Amersham, Pittsburgh, PA). Primer extensions were performed on 8 lmol of intron 3 RNA and 10 4 c.p.m. of 32 P-labeled BSK-R primer. Denaturation (95°C 1 min) and annealing (24°C 10 min) were completed in specific buffer (100 mM NaCl or KCl, 25 mM Tris-HCl pH 8.3, 10 mM MgCl 2 and 0.2 mM deoxynucleoside triphosphates) before extension (37°C, 30 min) using 30 U of AMV reverse transcriptase (RT) (Promega). Products were analyzed on 10% polyacrylamide-8 M urea gels following by autoradiography.
Green fluorescent protein-based reporter system A PvuI restriction site was introduced into the pEGFP-N3 plasmid immediately after the first ATG of green fluorescent protein (GFP) to produce the GFPPos plasmid. A negative control plasmid was produced by Klenow fragment digestion at PvuI site. A fragment from exon 2 to exon 4 of TP53 gene, excluding ATG 1 and 40, was cloned into the PvuI restriction site of GFPPos plasmid. Mutant GFP-D and GFP-DD plasmids were produced by QuickChangeÒ site-directed Mutagenesis Kit (Stratagene, Santa Clara, CA) (supplementary Table I available at Carcinogenesis Online). In six-well plates, 5 Â 10 5 of H1299 p53-null cells were transfected with 0.2 lg/ml of these plasmids using Fugene (Roche, Basel, Switzerland), RNA expression was analyzed by reverse transcription-polymerase chain reaction (PCR) (supplementary Table IIis available at Carcinogenesis Online), whereas GFP protein fluorescence was analyzed by flow cytometry.
Real-time PCR analysis
A lymphoblastoid cell line (BC9) expressing wild-type p53 and derived from breast cancer patient was used (28) . Total RNA was extracted using Trizol Reagent (Invitrogen TM , Carlsbad, CA). The level of each N-terminal variant p53 mRNA was analyzed using QuantiTect TM SyberÒ Green PCR Kit (Qiagen, Hamburg, Germany) and specific primers (supplementary Table I available at Carcinogenesis Online and Figure 5B ) and normalized to that of glycerAldehyde 3-phosphate dehydrogenase. The DCt was calculated as an average of three measurements by plate for two quantitative reverse transcription-PCR of at least two independent experiments. V.Marcel et al.
Statistical analyses
Analysis of variance and Student's t-tests were performed using online tools (http://faculty.vassar.edu/lowry/VassarStats.html).
Results

G-quadruplex structures in intron 3 of p53 mRNA TP53 intron 3 (93 bp) is rich in G bases (41%).
To analyze whether this TP53 region may contain motifs capable of forming G-quadruplex, the prediction software Quadfinder server and the web-based server QGRS Mapper were used (29, 30) . Using default parameters to predict G-quadruplex motifs over the whole gene sequence, four candidate regions were identified: two regions in intron 1, one in intron 3 and another in intron 6 (data for intron 3 in supplementary Figure 1A and Bis available at Carcinogenesis Online; data for other introns not shown). The predicted G-quadruplex-forming motif in intron 3 was located 60 bp downstream of the splice acceptor site of intron 2 (supplementary Figure 1A and Bis available at Carcinogenesis Online). This motif is predicted to carry up to 5 G-tracts sequences capable of forming G-quadruplex structures (supplementary Figure  1A and Bis available at Carcinogenesis Online).
To demonstrate the formation of G-quadruplex structures in TP53 intron 3, we synthesized three RNA oligomers derived from the Grich region of intron 3 ( Figure 1C , Table I ) and we analyzed their thermal stability under different ionic conditions by UV melting (Figure 2A ). For each of the three oligomers, the highest melting temperatures (T m ) were observed in K þ (10 mM) buffer (Oligo1: 57°C; Oligo2: 66.5°C and Oligo3: 75°C). T m was dependent on the nature of the cation, with T m (Li þ 100 mM) , T m (Na þ 100 mM) , T m (K þ 10 mM). This dependence is typical of the effect of these cations on the stability of G-quadruplexes. The T m values of Oligo2 and 3 in K þ 10 mM (66.5°C and 75°C, respectively) were higher than for Oligo1 (57°C), suggesting that G-quadruplexes in Oligo2 and 3 were more stable than in Oligo1. Oligo2 and 3 differ from Oligo1 by the presence of two tracts of six guanines in their 3# domain ( Figure 1C) , suggesting that these G-repeats are important for stable G-quadruplex formation.
To further demonstrate the presence of G4, we used two different biophysical methods. First, we analyzed the profiles of the three oligomers using UV TDS ( Figure 2B ) and CD spectroscopy ( Figure 2C) . A TDS is obtained by recording the UV absorbance spectra of the unfolded and folded states at temperatures above and below the melting temperature (T m ). The TDS profiles of the three oligomers showed a positive peak at 273 nm and a negative peak at 295 nm ( Figure 2B ). These two peaks are typical 'signatures' of G-quadruplex structures as determined by the analysis of different types of G-quadruplexes (24) . The variations in TDS profiles are independent of oligomer concentrations but reflect differences in sequence and in stability of G4. In particular, the low amplitude of the peaks observed with Oligo3 may be due to the fact that in this Oligo3, G-quadruplex structures are stable and only undergo partial unfolding within the temperature interval. CD spectroscopy also displayed changes in ellipticity, a characteristic of G-quadruplex structures, including a negative peak at 240 nm and a positive peak at 260 nm ( Figure 2C ). Overall, these results G-quadruplex and p53 splicing using synthetic RNA confirm in silico predictions and provide evidence that G-quadruplex structures can be formed in intron 3 of p53 RNA, involving in particular two G-repeats of six guanines.
Detection of G-quadruplexes by RT elongation assay Next, we used the RT elongation assay to further identify the position of guanines involved in G-quadruplexes (Figure 3 ). This method takes advantage of the differential cation-dependent stability of G-quadruplexes to identify structures that interfere with RT elongation (31) . K þ stabilizes G-quadruplexes, leading to a K þ -dependent block of complementary DNA synthesis at positions where guanines are involved in a G-quartet. In contrast, in the presence of Na þ , G-quadruplex stability is reduced, allowing complementary DNA synthesis to proceed without elongation block. A full-length RT product corresponding to the entire intron 3 RNA was detected in presence of Na þ (lane 5, '5#-intron 3' arrow in Figure 3 ). However, in the presence of K þ , stops of RT elongation were observed (lane 6) at positions corresponding to guanines on sequencing analysis, matching those predicted to form the 3# end of the G-quadruplexes. Thus, the detection of several RT-stops is compatible with in silico prediction and with spectrometric analyses indicating a critical role of two tracts of six guanines in the formation of several quadruplex conformers in intron 3.
Role of G-quadruplex in excision of intron 2 using an in vitro splicing assay Because alternative splicing of TP53 involves either retention (p53I2) or skipping (FSp53) of intron 2, we examined whether G-quadruplex in intron 3 were involved in the regulation of this splicing. To analyze the direct effect of G-quadruplexes on the splicing of intron 2, we constructed a minigene reporter based on GFP, in which a TP53 fragment from exons 2 to 4 was cloned between the ATG and the GFP coding sequence (GFP-E2E4, Figure 4A ). With this construct, correct splicing of intron 2 (FS-GFP) produces an mRNA that supports GFP synthesis, whereas retention of intron 2 (I2-GFP) introduces stop codons preventing GFP expression. Two mutant versions of the reporter were constructed, in which either one (GFP-E2E4D) or both (GFP-E2E4DD) two tracts of six guanines predicted to be involved in G-quadruplexes were substituted by site-directed mutagenesis ( Figure 4B ). To verify that the mutations introduced in GFP-E2E4DD abolished G-quadruplex formation, we synthesized an RNA oligomer, Oligo4, containing the same mutations ( Figure 4B and Table I ). When compared with Oligo2 and 3, Oligo4 did not show the typical patterns of G-quadruplexes detected by UV-melting curves, TDS and CD spectra (supplementary Figure 1A and Bis available at Carcinogenesis Online).
The p53-null cell line H1299 were transfected with the various GFP constructs. All constructs displayed equal transfection efficiency, as determined by reverse transcription-PCR analysis of expression of the neomycin gene carried by the plasmids ( Figure 4C ). When compared with cells expressing the wild-type GFP-E2E4 construct, cells transfected with GFP-E2E4D and -E2E4DD showed an increase in I2-GFP mRNA expression (retaining intron 2) and a decrease of FS-GFP mRNA expression (correct splice-out of intron 2). GFP fluorescence measurements showed that the wild-type GFP-E2E4 construct generated as much fluorescence as the positive GFP control (GFP-pos) (Figure 4) . Mutation of guanines resulted in a progressive decrease in fluorescence that depended upon the number of guanines mutated. A significant reduction of fluorescence of $25% was observed when comparing GFP-E2E4DD with GFP-E2E4 (P , 0.05). Taken together, these observations support the hypothesis that G-quadruplexes in intron 3 modulate the rate at which intron 2 is spliced-out. With wild-type intron 3 sequences presumably capable of forming stable G-quadruplexes, splicing of intron 2 appears to be more efficient than when G-quadruplex formation is crippled by mutations.
Effects of G-quadruplexes on p53 splicing in lymphoblastoid cells
To determine whether G-quadruplexes may modulate the splicing of p53 in intact cells, we analyzed the effect of a specific ligand of G-quadruplex structures, 360A, on the expression of FSp53 and p53I2 transcripts in lymphoblastoid cells using real-time PCR ( Figure 5 ). The ligand 360A has high affinity and stabilizing effects for G-quadruplex structures in single-stranded nucleic acids (21) . To demonstrate that 360A could bind to G-quadruplexes in intron 3 of p53 RNA, we used an fluorescence resonance energy transfer melting assay ( Figure 4A) (27) . A DNA oligonucleotide mimicking human telomeric motifs (F21T) was labeled with FAM at the 5# end and TAMRA at the 3# end (26, 27) . Addition of 360A induced a concentration-dependent stabilization of the G-quadruplex, resulting in an increased melting temperature (DT m ), at which fluorescence emission ceases due to unfolding of the G-quadruplex that suppresses fluorescence transfer. Excess amounts of unlabeled DNA or RNA were used as competitors to determine their capacity to displace 360A from its fluorescent target, thereby reducing its melting temperature. Figure  5A shows that Oligo1, 2 and 3 were capable of acting as competitors, in contrast with mutant Oligo4 and with negative control sequences RF16 and RK50. These results indicate that RNA quadruplexes formed in TP53 intron 3 could bind 360A, further extending the sequence repertoire of G4 structures bound by this ligand.
We next treated human lymphoblastoid cell line with 50 nM 360A for 48 h and analyzed its effects on p53 mRNA expression ( Figure 5B and C). Although 360A did not exert significant toxicity at the concentrations used (supplementary Figure 3 available at Carcinogenesis Online), it induced opposite, dose-dependent effects on levels of the two p53 transcripts, FSp53 and p53I2 ( Figure 5C ). Treatment by 360A resulted in a significant 3-fold increase in FSp53 mRNA. In contrast, p53I2 levels were significantly decreased by $40%. These results support the notion that G-quadruplexes are involved in the regulation of intron 2 splicing in intact cells.
Discussion
TP53 is expressed as several isoforms produced by different mechanisms, including alternative splicing (4,7). Differential splicing of intron 2 leads to the generation of FSp53 and p53I2 mRNAs that respectively encode the tumor suppressor p53 and the D40p53 isoform, which lacks the transactivation domain and acts as a negative regulator of p53 activity (7, 32) . Therefore, mechanisms that control the alternative splicing of intron 2 may have an effect on p53 activity by modifying the relative expression levels of p53 and of its D40p53 isoform. In this study, we show that a region of intron 3 forming G-quadruplex structures in p53 pre-mRNA is involved in the alternative splicing of TP53 intron 2. First, we used synthetic RNAs containing sequences of intron 3 and we show that these RNA can form G-quadruplexes using different spectrometric methods (UV melting, TDS and CD spectroscopy). Next, the presence of G-quadruplexes is further demonstrated by RT elongation assays. In these assays, demonstration of a G-quadruplex relies on the fact that these structures are very dependent upon the presence of specific cations, being stabilized in the presence of K þ and destabilized in the presence of Na þ . Furthermore, to demonstrate the involvement of these G-quadruplex structures in the splicing of intron 2, we have constructed a GFP reporter system in which fluorescence emission is dependent upon the correct excision of intron 2 sequences. Using this system, we show that mutation of guanines involved in G-quadruplexes significantly decreases the splicing-out of intron 2, however, without abolishing it. Finally, to demonstrate that G-quadruplexes in intron 3 can impact on p53 splicing in intact cells, we used a novel pharmacological ligand that stabilizes G-quadruplexes, 360A, in lymphoblastoid cells and we show that treatment with this ligand induces significant changes in the expression patterns of FSp53 (encoding p53) and p53I2 (encoding D40p53) mRNAs. Specifically, 360A increased the levels of FSp53 mRNA and decreased the ones of p53I2 mRNA, consistent with studies using the GFP reporter system showing that presence of stable G-quadruplexes is important for efficient splicing-out of intron 2.
The notion that G-quadruplex structures can modulate the alternative splicing of several genes is not new: it has been demonstrated in the case of b-tropomyosin, hTERT or Bcl-xL transcripts (11, 19, 33) . Compared with these examples, p53 G-quadruplexes show two important features. First, they are located in another intron (intron 3) than the one affected by alternative splicing (intron 2). This particular topography is due to the fact that introns and exons in this region are extremely short and some of the regulatory signals for the splicing of this intron may actually be located in intron 3. The splice acceptor of intron 2 is located just 60 bp upstream of the sequence forming G-quadruplexes. Second, the effects we demonstrate here are only partial. They do not induce a complete shift from one splicing pattern to the other, but rather modify the equilibrium between the two G-quadruplex and p53 splicing spliced products in a subtle manner. Using the GFP reporter system, the shift in splicing patterns observed after mutagenesis of candidate guanines is $25% (P , 0.05). In lymphoblastoid cells treated with 360A, we detect significant changes in the levels of both transcripts (P , 0.001), with a 3-fold increase for FSp53 and a 40% decrease for p53I2. These observations may be due, at least in part, to the fact that G-quadruplexes in intron 3 are polymorphic and may exist as different conformers. It is therefore possible that our site-directed mutagenesis experiments do not completely remove all G-quadruplex structures along the sequence of intron 3 but merely displace them or modify their organization. Furthermore studies will be necessary to uncover the full extent of the effect of G-quadruplexes on the splicing of intron 2.
The biological consequences of the regulatory effects identified here remain to be determined. Changes in transcript levels are expected to result into changes in the expression of both p53 protein isoforms when G-quadruplexes are stabilized, leading to increased p53 expression and decreased D40p53 expression. Indeed, we observed that 360A treatment resulted in a slight increased of p53 protein expression but we did not detect any significant impact on D40p53 protein levels or on the expression of the p53-target gene p21 WAF1 (supplementary Figure 4 available at Carcinogenesis Online). This suggests that 360A ligand modulates p53 splicing but that this effect does without significant activation of p53. Although p53 has a short half-life due to rapid recognition and proteasomedependent degradation by Hdm2, D40p53 escapes this regulation and is much more stable (3, 6) . Furthermore, the biological effect of D40p53 remains controversial. Biochemical evidence shows that D40p53 interacts with p53 protein to form hetero-tetramers and that excess amounts of D40p53 downregulate the transactivation capacity of p53. When cotransfected together with wild-type p53 in p53-null cells, D40p53 prevents growth suppression by p53 and enhances clonogenicity (3,5,11,34). However, there is no evidence from in vivo studies that D40p53 operates as a suppressor of p53 function. In mice with wild-type p53, increased dosage of D40p53 by expression of a transgene leads to accelerate aging and short lifespan. These mice display cognitive decline and synaptic impairment early in life, attributed to hyperactivation of insulin-like growth factor 1 receptor signaling and altered metabolism of the microtubule-binding protein tau (35, 36) . In human cells, D40p53 has been implicated in G 2 cell cycle arrest in response to endoplasmic reticulum stress (37) . Although the molecular mechanisms of these effects are not understood, both mouse and human models suggest that small variations of D40p53 are sufficient to modify p53 biological function. Another important consideration with respect to the potential impact of G-quadruplex in intron 3 is that they include guanine residues that are part of a common polymorphism, TP53 PIN3, consisting of a 16 bp duplication (rs17878362; A1: non-duplicated allele; A2: duplicated allele) (38, 39) . Several epidemiological case-control studies have identified that the carriers of the A2 allele had a significantly increased risk of several common cancers, including breast, colorectal, lung and ovarian cancers (28, (40) (41) (42) . Recently, we have reported that TP53 PIN3 is a genetic modifier of germ line TP53 mutation in the Li-Fraumeni Syndrome, the A1 allele being associated with earlier age at first cancer diagnosis (43) . Interestingly, Gemigniani et al. (28) described that p53 mRNA levels were lower in lymphoblastoid cell lines with A2 than with A1 alleles, suggesting that this polymorphism may affect the levels of p53 transcripts. In silico models predicts that TP53 PIN3 may alter the topology of G-quadruplexes in intron 3 (data not shown). However, the extent of these modifications and their consequences on p53 splicing remains to be investigated.
In conclusion, our results demonstrate that G-quadruplexes are present in intron 3 of TP53 gene and provide support in favor of a role of these structures in the regulation of the alternative splicing of intron 2, thus modulating the patterns of expression of transcripts encoding either p53 or its N-terminally truncated isoform, D40p53.
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